Cell Proliferation in Ovarian Carcinoma: Superior Accuracy of S-Phase Fraction (SPF) by DNA Labeling Index versus Flow Cytometric SPF, Lack of Independent Prognostic Power for SPF and DNA Ploidy, and Limited Effect of SPF on Tumor Growth Rate

By Meyer J.S.   Gersell D.J.   Yim S.  

Gynecologic Oncology, Vol. 81, Iss. 3, 2001-06 ,pp. : 466-476

Elsevier

Access to resources Recommend Favorite

Identification of Prognostic Factors in Advanced Epithelial Ovarian Carcinoma

By Chi D.S.   Liao J.B.   Leon L.F.   Venkatraman E.S.   Hensley M.L.   Bhaskaran D.   Hoskins W.J.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 532-537

Elsevier

Access to resources Recommend Favorite

Whole blood RNA expression profiles in ovarian cancer patients with or without residual tumors after primary cytoreductive surgery

By      

Oncology Reports, Vol. 27, Iss. 5, 2012-01 ,pp. : 1331-1335

Spandidos Publications

Access to resources Recommend Favorite

Histological Regression of Squamous Esophageal Carcinoma Assessed by Percentage of Residual Viable Cells after Neoadjuvant Chemoradiation is an Important Prognostic Factor

By Tong Daniel  

Annals of Surgical Oncology, Vol. 17, Iss. 8, 2010-08 ,pp. : 2184-2192

Springer Publishing Company

Access to resources Recommend Favorite

Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer

By Moureau-Zabotto L.  

Breast Cancer Research and Treatment, Vol. 91, Iss. 1, 2005-05 ,pp. : 61-71

Springer Publishing Company

Access to resources Recommend Favorite